RAPP vs RHI · rev $20.0M vs P/E 21, rev $5.38B
Rapport Therapeutics, Inc. Common Stock (RAPP) versus Robert Half International Inc (RHI) — a side-by-side from cached financials, not a winner call.
Rapport Therapeutics, Inc. Common Stock (RAPP) is a biotechnology company listed on US.
Robert Half International Inc (RHI) is a staffing & employment services company listed on US.
Latest reported RAPP revenue for 2026-06-30 was $20.0M. Net income was -$76.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. RAPP currently screens at market cap $532.9M.
Latest reported RHI revenue for 2025-12-31 was $5.38B. Net income was $133.0M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
RAPP currently screens at market cap $532.9M. RHI currently screens at market cap $4.38B and trailing P/E 21.4.
Not investment advice. Open the RAPP and RHI stock pages for the full models.
Not investment advice.